Adenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion.

scientific article published on 10 September 2011

Adenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.NBD.2011.08.030
P932PMC publication ID3235740
P698PubMed publication ID21964253
P5875ResearchGate publication ID51687875

P50authorJoshua A GoldbergQ56501403
P2093author name stringD James Surmeier
Jayms D Peterson
P2860cites workLTP and LTDQ22337342
A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiationQ24305050
Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitryQ24630976
A2A antagonists as novel non-dopaminergic therapy for motor dysfunction in PDQ28190142
Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complicationsQ28247343
Adenosine A2A and dopamine D2 heteromeric receptor complexes and their functionQ28261240
Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse numberQ28297899
Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTPQ28377464
Structural basis of long-term potentiation in single dendritic spinesQ29547598
The functional anatomy of basal ganglia disordersQ29617461
FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticityQ30491749
Dichotomous dopaminergic control of striatal synaptic plasticityQ30493521
Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptorsQ30495714
Thalamic gating of corticostriatal signaling by cholinergic interneurons.Q30583147
The N-methyl-D-aspartate receptor antagonist CPP alters synapse and spine structure and impairs long-term potentiation and long-term depression induced morphological plasticity in dentate gyrus of the awake rat.Q30955643
Differential excitability and modulation of striatal medium spiny neuron dendritesQ33382961
Distribution, biochemistry and function of striatal adenosine A2A receptorsQ33740841
Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons.Q34521936
The thalamostriatal system: a highly specific network of the basal ganglia circuitryQ34550491
Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function.Q34638023
A2A receptor and striatal cellular functions: regulation of gene expression, currents, and synaptic transmissionQ35603269
Dopamine agonists, receptor selectivity and dyskinesia induction in Parkinson's diseaseQ35793502
Adenosine A2A receptor antagonists for Parkinson's disease: rationale, therapeutic potential and clinical experienceQ36172464
Adenosine-dopamine interactions revealed in knockout mice.Q36191606
Modulation of striatal projection systems by dopamineQ36367283
Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonismQ36763909
Homeostatic signaling: the positive side of negative feedbackQ36798818
Re-emergence of striatal cholinergic interneurons in movement disordersQ36955354
Cholinergic modulation of multivesicular release regulates striatal synaptic potency and integrationQ37323686
Dopamine and synaptic plasticity in dorsal striatal circuits controlling action selectionQ37629163
Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's diseaseQ39732881
Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transferQ40599836
MEF-2 regulates activity-dependent spine loss in striatopallidal medium spiny neurons.Q40817289
Locally dynamic synaptic learning rules in pyramidal neuron dendritesQ42287800
Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats.Q42493069
Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's diseaseQ42497576
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease modelsQ42508054
Corticostriatal and thalamostriatal synapses have distinctive propertiesQ42551042
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drugQ43232822
Adenosine receptor expression and function in rat striatal cholinergic interneuronsQ43264704
G-protein-coupled receptor modulation of striatal CaV1.3 L-type Ca2+ channels is dependent on a Shank-binding domain.Q45249950
D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism.Q45980594
Cholinergic suppression of KCNQ channel currents enhances excitability of striatal medium spiny neurons.Q46644376
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models.Q46896175
Cholinergic modulation of Kir2 channels selectively elevates dendritic excitability in striatopallidal neurons.Q46973834
Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP.Q48226289
Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway.Q48391594
Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genesQ48433708
Warmer preparation of hippocampal slices prevents synapse proliferation that might obscure LTP-related structural plasticityQ48452247
Downregulation of transient K+ channels in dendrites of hippocampal CA1 pyramidal neurons by activation of PKA and PKC.Q48455965
RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletionQ48540394
The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D2/A2A Receptor Interaction in the Striatum: Implications for Parkinson's DiseaseQ60715991
Adenosine A2a receptor-mediated modulation of striatal acetylcholine release in vivo.Q67401851
Muscarinic (m2/m4) receptors reduce N- and P-type Ca2+ currents in rat neostriatal cholinergic interneurons through a fast, membrane-delimited, G-protein pathwayQ71483852
Adenosine receptor expression and modulation of Ca(2+) channels in rat striatal cholinergic interneuronsQ73352680
Probing fundamental aspects of synaptic transmission with strontiumQ73870623
P433issue1
P921main subjectstriatumQ1319792
P304page(s)409-416
P577publication date2011-09-10
P1433published inNeurobiology of DiseaseQ15716606
P1476titleAdenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion
P478volume45

Reverse relations

cites work (P2860)
Q39502291A role for dopamine-mediated learning in the pathophysiology and treatment of Parkinson's disease.
Q37048087Aberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: involvement of corticostriatal but not thalamostriatal synapses
Q30650489Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia
Q36889608Chronic Nicotine Mitigates Aberrant Inhibitory Motor Learning Induced by Motor Experience under Dopamine Deficiency
Q48309715Deconstructing behavioral neuropharmacology with cellular specificity
Q92000933Diverse Mechanisms Lead to Common Dysfunction of Striatal Cholinergic Interneurons in Distinct Genetic Mouse Models of Dystonia
Q35898412Endocannabinoid-dopamine interactions in striatal synaptic plasticity
Q34362073Exercise modifies α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor expression in striatopallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse
Q48541253Haloperidol Selectively Remodels Striatal Indirect Pathway Circuits
Q33692607Modulation of Ca2+-currents by sequential and simultaneous activation of adenosine A1 and A 2A receptors in striatal projection neurons.
Q52370795Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases.
Q38038559New synaptic and molecular targets for neuroprotection in Parkinson's disease
Q36914301Npas1+ Pallidal Neurons Target Striatal Projection Neurons
Q47843003On the role of adenosine (A)₂A receptors in cocaine-induced reward: a pharmacological and neurochemical analysis in rats
Q39157893Pathological overproduction: the bad side of adenosine.
Q38142090The Enemy within: Propagation of Aberrant Corticostriatal Learning to Cortical Function in Parkinson's Disease
Q33971113Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review.